SE447107B - Nya 4-aroylimidazol-2-oner - Google Patents

Nya 4-aroylimidazol-2-oner

Info

Publication number
SE447107B
SE447107B SE8004253A SE8004253A SE447107B SE 447107 B SE447107 B SE 447107B SE 8004253 A SE8004253 A SE 8004253A SE 8004253 A SE8004253 A SE 8004253A SE 447107 B SE447107 B SE 447107B
Authority
SE
Sweden
Prior art keywords
methyl
carbon atoms
straight
imidazol
branched lower
Prior art date
Application number
SE8004253A
Other languages
English (en)
Swedish (sv)
Other versions
SE8004253L (sv
Inventor
R A Schnettler
R C Dage
J M Grisar
Original Assignee
Richardson Merrell Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26727558&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SE447107(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Richardson Merrell Inc filed Critical Richardson Merrell Inc
Publication of SE8004253L publication Critical patent/SE8004253L/xx
Publication of SE447107B publication Critical patent/SE447107B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/70—One oxygen atom
SE8004253A 1979-06-18 1980-06-06 Nya 4-aroylimidazol-2-oner SE447107B (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US4980879A 1979-06-18 1979-06-18
US11920780A 1980-02-07 1980-02-07

Publications (2)

Publication Number Publication Date
SE8004253L SE8004253L (sv) 1980-12-19
SE447107B true SE447107B (sv) 1986-10-27

Family

ID=26727558

Family Applications (2)

Application Number Title Priority Date Filing Date
SE8004253A SE447107B (sv) 1979-06-18 1980-06-06 Nya 4-aroylimidazol-2-oner
SE8501452A SE464559B (sv) 1979-06-18 1985-03-25 Farmaceutisk komposition innehaallande 4-aroylimidazol-2-oner med antihypertensiv, kardioton och antitrombotisk verkan

Family Applications After (1)

Application Number Title Priority Date Filing Date
SE8501452A SE464559B (sv) 1979-06-18 1985-03-25 Farmaceutisk komposition innehaallande 4-aroylimidazol-2-oner med antihypertensiv, kardioton och antitrombotisk verkan

Country Status (20)

Country Link
AT (1) AT375349B (de)
AU (1) AU532783B2 (de)
CA (1) CA1132554A (de)
CH (1) CH646155A5 (de)
DE (1) DE3021792A1 (de)
DK (1) DK160269C (de)
ES (1) ES492255A0 (de)
FR (1) FR2459233A1 (de)
GB (1) GB2055364B (de)
HK (1) HK61486A (de)
HU (1) HU186736B (de)
IE (1) IE50646B1 (de)
IL (1) IL60243A (de)
IT (1) IT1143922B (de)
MY (1) MY8600709A (de)
NL (2) NL193752C (de)
NO (1) NO152841C (de)
NZ (1) NZ193935A (de)
PH (1) PH18683A (de)
SE (2) SE447107B (de)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH18106A (en) * 1981-02-18 1985-03-21 Merrell Dow Pharma Novel-4-aroylimidazol-2-ones
US4405628A (en) * 1981-03-05 1983-09-20 Merrell Dow Pharmaceuticals Inc. 4-Pyridylimidazolones and method of use
US4526981A (en) * 1981-05-04 1985-07-02 Merrell Dow Pharmaceuticals Inc. [1,2-Dihydro-4(5)-acyl-2-oxo-2H-imidazol-4(5)-yl] methyl nitrates
US4371737A (en) * 1981-05-04 1983-02-01 Merrell Dow Pharmaceuticals Inc. 5-Aminomethyl-2,3-dihydro-2-oxo-1H-imidazole-4-carboxylic acid derivatives
GB2097792B (en) * 1981-05-04 1985-01-03 Merrell Dow Pharma 1,3-dihydro-2h-imidazol-2-ones
US4329470A (en) 1981-05-04 1982-05-11 Merrell Dow Pharmaceuticals Inc. 5-(4-Phenyl 1-piperidinyl)methyl-2,3-dihydro-2-oxo-1H-imidazole-4-carboxylic acid derivatives
US4329471A (en) * 1981-05-04 1982-05-11 Merrell Dow Pharmaceuticals Inc. 4-(4-Phenyl-1-piperidinyl)methyl-5-acyl-1,3-dihydro-2H-imidazol-2-ones
US4381393A (en) * 1981-05-04 1983-04-26 Merrell Dow Pharmaceuticals Inc. 4-Aminomethyl-5-acyl-1,3-dihydro-2H-imidazol-2-ones
US4367236A (en) 1981-11-04 1983-01-04 Merrell Dow Pharmaceuticals Inc. Method for the treatment of cardiac failure with alkanoylimidazol-2-one derivatives
US4410540A (en) * 1981-11-04 1983-10-18 Merrell Dow Pharmaceuticals Inc. Cardiotonic 4-aroylimidazolidin-2-ones
US7772188B2 (en) 2003-01-28 2010-08-10 Ironwood Pharmaceuticals, Inc. Methods and compositions for the treatment of gastrointestinal disorders
JP2007530563A (ja) * 2004-03-22 2007-11-01 ミオゲン インコーポレイティッド （ｓ）−エノキシモンスルホキシドおよびｐｄｅ−ｉｉｉ媒介疾患の治療におけるその使用
US20060030611A1 (en) * 2004-03-22 2006-02-09 Myogen, Inc. Enoximone sulfoxide enantiomers and their use in the treatment of PDE-III mediated diseases
US8067433B2 (en) 2005-11-09 2011-11-29 Zalicus Inc. Methods, compositions, and kits for the treatment of ophthalmic disorders
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
CA3089569C (en) 2007-06-04 2023-12-05 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
JP2011522828A (ja) 2008-06-04 2011-08-04 シナジー ファーマシューティカルズ インコーポレイテッド 胃腸障害、炎症、癌、およびその他の障害の治療のために有用なグアニル酸シクラーゼのアゴニスト
EP2321341B1 (de) 2008-07-16 2017-02-22 Synergy Pharmaceuticals Inc. Zur behandlung von erkrankungen des magen-darm-trakts, entzündlichen erkrankungen, krebs und anderen erkrankungen geeignete agonisten von guanylatcyclase
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
CA2828346C (en) 2011-03-01 2021-01-26 Synergy Pharmaceuticals Inc. Process of preparing guanylate cyclase c agonists
EP2804603A1 (de) 2012-01-10 2014-11-26 President and Fellows of Harvard College Betazellen-replikation für promoterverbindungen und verwendungsverfahren dafür
US9545446B2 (en) 2013-02-25 2017-01-17 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase and their uses
US9486494B2 (en) 2013-03-15 2016-11-08 Synergy Pharmaceuticals, Inc. Compositions useful for the treatment of gastrointestinal disorders
EP2970384A1 (de) 2013-03-15 2016-01-20 Synergy Pharmaceuticals Inc. Agonisten der guanylatcyclase und deren verwendungen
JP6606491B2 (ja) 2013-06-05 2019-11-13 シナジー ファーマシューティカルズ インコーポレイテッド グアニル酸シクラーゼｃの超高純度アゴニスト、その作成および使用方法
KR20160042039A (ko) 2013-08-09 2016-04-18 알데릭스, 인코포레이티드 인산염 수송을 억제하기 위한 화합물 및 방법
EP3972599A1 (de) 2019-05-21 2022-03-30 Ardelyx, Inc. Kombination zur senkung des serum-phosphatspiegels bei einem patienten
CN114539157B (zh) * 2022-03-03 2023-12-22 曲靖师范学院 一种碘促进氧化法制备4-碘代n-芳基吡唑类化合物的方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2441933A (en) * 1945-07-30 1948-05-18 Hoffmann La Roche Substituted imidazolones and process of making them

Also Published As

Publication number Publication date
DE3021792A1 (de) 1981-01-22
FR2459233A1 (fr) 1981-01-09
AT375349B (de) 1984-07-25
DK160269C (da) 1991-07-22
DK259080A (da) 1980-12-19
ES8105299A1 (es) 1981-06-01
NL300015I1 (nl) 2000-11-01
GB2055364A (en) 1981-03-04
CA1132554A (en) 1982-09-28
NL193752C (nl) 2000-09-04
IE801162L (en) 1980-12-18
CH646155A5 (de) 1984-11-15
IE50646B1 (en) 1986-06-11
FR2459233B1 (de) 1983-09-23
NL8003498A (nl) 1980-12-22
IL60243A (en) 1987-01-30
NL300015I2 (nl) 2000-10-02
SE8501452L (sv) 1985-03-25
IT1143922B (it) 1986-10-29
NO152841C (no) 1985-11-27
NL193752B (nl) 2000-05-01
SE464559B (sv) 1991-05-13
PH18683A (en) 1985-08-29
NZ193935A (en) 1985-05-31
IL60243A0 (en) 1980-09-16
DE3021792C2 (de) 1989-08-10
DK160269B (da) 1991-02-18
HU186736B (en) 1985-09-30
MY8600709A (en) 1986-12-31
ATA314280A (de) 1983-12-15
AU532783B2 (en) 1983-10-13
NO801796L (no) 1980-12-19
ES492255A0 (es) 1981-06-01
NO152841B (no) 1985-08-19
SE8501452D0 (sv) 1985-03-25
GB2055364B (en) 1983-06-08
AU5911880A (en) 1981-01-08
IT8048997A0 (it) 1980-06-17
SE8004253L (sv) 1980-12-19
HK61486A (en) 1986-08-29

Similar Documents

Publication Publication Date Title
SE447107B (sv) Nya 4-aroylimidazol-2-oner
RU2075478C1 (ru) 2-(4-этил-1-пиперазинил)-4-(4-фторфенил)-5,6,7,8,9,10-гексагидроциклоокта (в) пиридин или его кислотно-аддитивная соль
EP0079545B1 (de) Benzimidazol-Derivate, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Zusammensetzungen
US4405635A (en) 4-Aroylimidazol-2-ones and their use as pharmaceuticals
KR890000765B1 (ko) 아로일이미다졸론 및 그의 제조방법
US4470989A (en) Neuroleptic n-oxacyclyl-alkylpiperidine derivatives
SI20269A (sl) Derivati acil-piperazinil-pirimidinov, njihova priprava in uporaba kot zdravila
EP0093521B1 (de) Chinolinderivate
WO1999064407A1 (en) α-(1-PIPERAZINYL)ACETAMIDO ARENECARBOXYLIC ACID DERIVATIVES AS ANTIDIABETIC AGENTS
CA1173047A (en) 4-aroylimidazol-2-ones
EP0435177B1 (de) 4-Benzyl-5-phenyl-2,4-dihydro-3H-1,2,4-triazol-3-one und ihre Verwendung als Antikonvulsiva
JPH0223548B2 (de)
EP0079050B1 (de) 4-Aroylimidazolidin-2-one
CA1250577A (en) Sparsomycin derivatives
KR900000368B1 (ko) 5-헤테로사이클릭-2, 4-디알킬-3h-1, 2, 4-트리아졸-3-티온 및 이의 제조방법
NZ224224A (en) Thiadiazole guanidines and medicaments
CS202053B2 (cs) Způsob přípravy nových 4-[2-imidazolin-2-yl-amino]-2,1,3-benzothiadiazolových derivátů
EP1091947A1 (de) Alpha-(1-piperazinyl) acetamidoarencarbonsäurederivate als antidiabetika

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 8004253-4

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 8004253-4

Format of ref document f/p: F